Researchers Develop Novel Treatment Option for Triple Negative Breast Cancer
A researcher at the University of Houston College of Pharmacy has joined a $3.2 million effort to develop a promising new treatment for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease, accounting for 10-15% of all breast cancer cases.